References

1. Heuck G: Zwei falle von Leukamie mit eigenthum-lichem blut-resp knochenmarksbefund. Arch Pathol Physiol Klinische Med 78:475-496, 1879.

2. Jackson H, Lemon H: Agnogenic myeloid metaplasia of the spleen: a syndrome simulating other more definite hematologic disorders. N Engl J Med 222:985-994, 1940.

3. Tefferi A: Myelofibrosis with myeloid metaplasia. N Engl J Med 342:1255-1265, 2000.

4. Hirsch E: Generalized osteosclerosis with chronic polycythemia vera. Arch Pathol 19:91-97, 1935.

5. Jacobsen R, Salo A, Fialkow P: Agnogeneic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 51:189, 1978.

6. Mesa RA, Hanson CA, Rajkumar SV, Schroeder G, Tefferi A: Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia. Blood 96:3374-3380, 2000.

7. Mesa RA, Silverstein MN, Jacobsen SJ, Wollan PC, Tefferi A: Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County study, 1976— 1995. Am JHematol 61:10-15, 1999.

8. Mesa RA, Li CY, Schroeder G, Tefferi A: Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia. Blood 97:3665-3667, 2001.

9. Tefferi A, Mesa RA, Nagorney DM, Schroeder G, Silverstein MN: Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood 95:2226-2233, 2000.

appropriate for a particular patient. If the patient is a transplant candidate, but currently is stable and at low risk, observation or minimally toxic therapies may be used as short-term interventions, with consideration of the transplant at time of progression.

0 0

Post a comment